Abeona Therapeutics (ABEO) Return on Sales (2011 - 2026)

Abeona Therapeutics' Return on Sales history runs 15 years deep, the most recent figure standing at 0.02% for Q1 2026.

• On a quarterly basis, Return on Sales changed N/A year-over-year to 0.02% in Q1 2026; TTM through Mar 2026 was 0.05%, a N/A change from a year earlier, with the FY2025 full-year figure at 0.1%, changed N/A from the prior year.
• Return on Sales grew to 0.02% in Q1 2026 per ABEO's latest filing, from 0.07% in the prior quarter.
• Across five years, Return on Sales topped out at 3.11% in Q2 2025 and bottomed at 1.93% in Q4 2022.
• The 5-year median for Return on Sales is 0.16% (2023), against an average of 0.08%.
• Biggest YoY gain for Return on Sales was 176 bps in 2023; the steepest drop was 8 bps in 2023.
• Year by year, Return on Sales stood at 1.93% in 2022, then soared by 91 bps to 0.17% in 2023, then climbed by 8 bps to 0.15% in 2024, then surged by 58 bps to 0.07% in 2025, then surged by 70 bps to 0.02% in 2026.
• Per Business Quant, the three latest ABEO Return on Sales figures stand at 0.02% (Q1 2026), 0.07% (Q4 2025), and 2.46% (Q3 2025).